Inventor · disambiguated record
Maurizio Pellecchia
Also filed as: PELLECCHIA MAURIZIO
24 granted patents·26 pending applications·55 citations·filing 2000–2025
93Inventor score
Files withBURNHAM INST MEDICAL RESEARCH13TRIAD THERAPEUTICS INC6BURNHAM INST5PELLECCHIA MAURIZIO5UNIV CALIFORNIA5
Top patents by PatentIndex Score
50 records- 0191US7718680B2Inhibition of lethal factor protease activity from anthrax toxinBURNHAM INST MEDICAL RESEARCH·Filed 2005·Granted May 18, 2010·13 cites·6 claims
- 0286US8039668B2Naphthalene-based inhibitors of anti-apoptotic proteinsBURNHAM INST MEDICAL RESEARCH·Filed 2010·Granted Oct 18, 2011·9 cites·25 claims
- 0383US7947717B2Inhibitors of lethal factor proteaseBURNHAM INST MEDICAL RESEARCH·Filed 2008·Granted May 24, 2011·4 cites·5 claims
- 0481US11891399B2Inhibitors of cancer invasion, attachment, and/or metastasisUNIV VIRGINIA COMMONWEALTH·Filed 2021·Granted Feb 6, 2024·1 cites·25 claims
- 0575US2024360138A1Inhibitors of cancer invasion, attachment, and/or metastasisUNIV VIRGINIA COMMONWEALTH·Filed 2023·Application pending·0 cites
- 0674US11590197B2Agents targeting inhibitor of apoptosis proteinsUNIV CALIFORNIA·Filed 2018·Granted Feb 28, 2023·2 cites·17 claims
- 0773US11008325B2Inhibitors of cancer invasion, attachment, and/or metastasisUNIV VIRGINIA COMMONWEALTH·Filed 2017·Granted May 18, 2021·1 cites·50 claims
- 0872US8937193B2Apogossypolone derivatives as anticancer agentsPELLECCHIA MAURIZIO·Filed 2010·Granted Jan 20, 2015·3 cites·11 claims
- 0972US7812058B2Methods and compounds useful to induce apoptosis in cancer cellsBURNHAM INST·Filed 2004·Granted Oct 12, 2010·4 cites·1 claims
- 1071US8431529B2Bi-dentate compounds as kinase inhibitorsPELLECCHIA MAURIZIO·Filed 2010·Granted Apr 30, 2013·1 cites·10 claims
- 1164US6620589B1NMR-solve method for rapid identification of Bi-ligand drug candidatesTRAID THERAPEUTICS INC·Filed 2000·Granted Sep 16, 2003·9 cites·62 claims
- 1263US2010041653A1Composition and methods for the design and development of metallo-enzyme inhibitorsBURNHAM INST MEDICAL RESEARCH·Filed 2009·Application pending·0 cites
- 1362US7951832B2Pyrazole derivatives as kinase inhibitorsBURNHAM INST MEDICAL RESEARCH·Filed 2008·Granted May 31, 2011·0 cites·6 claims
- 1459US11732007B2Therapeutic compounds and methodsUNIV CALIFORNIA·Filed 2021·Granted Aug 22, 2023·0 cites·2 claims
- 1559US7252931B2NMR-solve method for rapid identification of bi-ligand drug candidatesTRIAD THERAPEUTICS INC·Filed 2004·Granted Aug 7, 2007·2 cites·42 claims
- 1659US6797460B2NMR-solve method for rapid identification of bi-ligand drug candidatesTRIAD THERAPEUTICS INC·Filed 2001·Granted Sep 28, 2004·2 cites·160 claims
- 1756US7741521B2Inhibition of bid-induced cell-death using small organic moleculesBURNHAM INST·Filed 2006·Granted Jun 22, 2010·0 cites·8 claims
- 1856US2007298439A1Nmr-solve method for rapid identification of bi-ligand drug candidatesTRIAD THERAPEUTICS INC·Filed 2007·Application pending·0 cites
- 1955US8367644B2Methods and compounds useful to induce apoptosis in cancer cellsBURNHAM INST·Filed 2010·Granted Feb 5, 2013·0 cites·9 claims
- 2055US7723076B2Use of selective labeling to detect and characterize molecular interactions by nuclear magnetic resonance spectroscopyBURNHAM INST·Filed 2006·Granted May 25, 2010·0 cites·24 claims
- 2153US7653490B2Nuclear magnetic resonance assembly of chemical entitiesTriad Liquidating Company LLC·Filed 2002·Granted Jan 26, 2010·2 cites·17 claims
- 2252US8436207B2Naphthalene-based inhibitors of anti-apoptotic proteinsPELLECCHIA MAURIZIO·Filed 2011·Granted May 7, 2013·0 cites·15 claims
- 2352US2012269901A1Methods and Compounds Useful to Induce Apoptosis in Cancer CellsREED JOHN C·Filed 2011·Application pending·0 cites
- 2451US11739121B2EPHA2 agonists and uses thereofUNIV CALIFORNIA·Filed 2019·Granted Aug 29, 2023·0 cites·5 claims
- 2551US9115061B2Naphthalene-based inhibitors of anti-apoptotic proteinsPELLECCHIA MAURIZIO·Filed 2008·Granted Aug 25, 2015·0 cites·5 claims
- 2651US2009258914A1Inhibitor of Anti-Apoptotic ProteinsBURNHAM INST MEDICAL RESEARCH·Filed 2009·Application pending·0 cites
- 2750US2010168162A1Selective inhibitors of akt and methods of using sameBURNHAM INST MEDICAL RESEARCH·Filed 2009·Application pending·0 cites
- 2850US2009124675A1Inhibitors of anti-apoptotic proteinsBURNHAM INST MEDICAL RESEARCH·Filed 2008·Application pending·0 cites
- 2949US2004132102A1Use of selective labeling to detect and characterize molecular interactions by nuclear magnetic resonance spectroscopyFiled 2003·Application pending·0 cites
- 3047US2010298390A1Inhibition of lethal factor protease activity from anthrax toxinBURNHAM INST MEDICAL RESEARCH·Filed 2010·Application pending·0 cites
- 3147US2008293721A1Arylthioacetamide carboxylate derivatives as fkbp inhibitors for the treatment of neurological diseasesBURNHAM INST MEDICAL RESEARCH·Filed 2008·Application pending·0 cites
- 3247US2005042674A9Common ligand mimics: thiazolidinediones and rhodaninesFiled 2002·Application pending·0 cites
- 3346US2011212961A1Pyrazole Derivatives as Kinase InhibitorsBURNHAM INST MEDICAL RESEARCH·Filed 2011·Application pending·0 cites
- 3446US2003008326A1Nuclear magnetic resonance-docking of compoundsFiled 2002·Application pending·0 cites
- 3545US2023203096A1Epha4 targeting compounds and methods of use thereofUNIV CALIFORNIA·Filed 2021·Application pending·0 cites
- 3644US8487131B2Optically pure apogossypol derivative as pan-active inhibitor of anti-apoptotic B-cell lymphoma/leukemia-2 (BCL-2)PELLECCHIA MAURIZIO·Filed 2010·Granted Jul 16, 2013·0 cites·16 claims
- 3744US2010261788A1Inhibition of Bid-Induced Cell-Death Using Small Organic MoleculesBURNHAM INST·Filed 2010·Application pending·0 cites
- 3844US2025296955A1Pin1 targeting compounds and degraders and methods thereofUNIV CALIFORNIA·Filed 2025·Application pending·0 cites
- 3943US2009312352A1Compositions and methods for treatment of disease caused by yersinia spp infectionMUSTELIN TOMAS MIKAEL·Filed 2005·Application pending·0 cites
- 4042US6979531B2SEA-TROSY and related methodsTRIAD THERAPEUTICS INC·Filed 2001·Granted Dec 27, 2005·2 cites·47 claims
- 4142US2009131474A1Screening methods for protein kinase b inhibitors employing virtual docking approaches and compounds and compositions discovered therebyFORINO MARTINO·Filed 2006·Application pending·0 cites
- 4242US2005234652A1Nuclear magnetic resonance-docking of compoundsTRIAD THERAPEUTICS INC·Filed 2005·Application pending·0 cites
- 4340US2006166279A1Sea-trosy and related methodsTRIAD THERAPEUTICS INC·Filed 2005·Application pending·0 cites
- 4439US2005019825A9Common ligand mimics: pseudothiohydantoinsFiled 2002·Application pending·0 cites
- 4538US9266828B2Inhibitors of Furin and other pro-protein convertasesSANFORD BURNHAM MED RES INST·Filed 2013·Granted Feb 23, 2016·0 cites·11 claims
- 4636US2015051138A1Inhibitors of furin and other pro-protein convertasesSANFORD BURNHAM MED RES INST·Filed 2013·Application pending·0 cites
- 4735US2010240720A1Allosteric jnk inhibitorsBURNHAM INST MEDICAL RESEARCH·Filed 2010·Application pending·0 cites
- 4835US2012190707A1Selective inhibitors of akt and methods of using sameRONAI ZE EV·Filed 2012·Application pending·0 cites
- 4935US2010240594A1Targeted delivery of chemotherapeutic agentsBURNHAM INST MEDICAL RESEARCH·Filed 2010·Application pending·0 cites
- 5033US2018127464A1Novel epha4 inhibitors targeting its ligand binding domainSANFORD BURNHAM MED RES INST·Filed 2016·Application pending·0 cites
Join the waitlist — get patent alerts
Get an alert when Maurizio Pellecchia files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →